Professional Documents
Culture Documents
PRACTICE
.
EMPRACTICE NET
A N E V I D E N C E - B A S E D A P P ROAC H T O E M E RG E N C Y M E D I C I N E
January 2004
Syncope: An ED Approach
To Risk Stratification
Volume 6, Number 1
Authors
Its Sunday morning. Youve just discharged the last Saturday night warrior from the
ED when you get a call that the local EMS crew is bringing in a woman who has had a
syncopal episode at church. When the crew arrives, you get a typical story from the
paramedic. Shes a 44-year-old woman who was sitting during a 20-minute sermon.
When the congregation stood, she stood and then fell to the ground. She awoke seconds
after falling, no serious injuries noted. She takes a heart pill of some kind, and a water
pill. She says she has high blood pressure. Heart rate on our monitor was 60 and normal
sinus. BP in the left arm was 110/64. Sats 99% on two liters. No other complaints. Her
husband is on the way.
You introduce yourself to the patient, who tells you that her heart doctor recently
increased the dose of her heart pill. The patient thinks this might be the problem. She
denies any serious symptoms now or before the event. Youre thinking, Too much betablockercase solved. Just then, the patients anxious husband arrives. He corroborates
the EMS story. Then he adds, I sure hope this isnt that bleed on her brain like the last
time she passed out in church. Her heart doctor also said we should watch out for the
main blood vessel in her chest. It was big on the last scan they took.
So much for the slam-dunk case.
Associate Editor
Andy Jagoda, MD, FACEP, ViceChair of Academic Affairs,
Department of Emergency
Medicine; Residency Program
Director; Director, International
Studies Program, Mount Sinai
School of Medicine, New York, NY.
Editorial Board
Judith C. Brillman, MD, Associate
Professor, Department of
Emergency Medicine, The
University of New Mexico Health
of Emergency Medicine,
Thomas Jefferson University,
Philadelphia, PA.
Corey M. Slovis, MD, FACP, FACEP,
Professor of Emergency Medicine
and Chairman, Department of
Emergency Medicine, Vanderbilt
University Medical Center; Medical
Director, Metro Nashville EMS,
Nashville, TN.
Mark Smith, MD, Chairman,
Department of Emergency
Medicine, Washington Hospital
Center and Georgetown
University School of Medicine,
Washington, DC.
Charles Stewart, MD, FACEP, Colorado
Springs, CO.
Thomas E. Terndrup, MD, Professor
and Chair, Department of
Emergency Medicine, University
of Alabama at Birmingham,
Birmingham, AL.
COPYRIGHTED MATERIALDO NOT PHOTOCOPY OR DISTRIBUTE ELECTRONICALLY WITHOUT WRITTEN CONSENT OF EB PRACTICE, LLC
Cardiogenic Syncope
There are many cardiac-related causes of syncope, but they
can all generally be placed into one of two categories. The
cause of syncope can be due to a primary dysrhythmia or
related to obstruction of blood flow. The obstruction-to-flow
category can be further subdivided into obstructive and
vascular causes. (Review Table 1 for a list of common
causes under each category.) Inadequate cardiac output is
the underlying premise in all of these patients with cardiogenic syncope.
Pathophysiology
Syncope is defined as a sudden and transient loss of
consciousness associated with a loss of postural tone, with a
spontaneous and full recovery. There is also an absence of
Noncardiac Causes
aortic aneurysm
Subclavian steal
syndrome
Subarachnoid
hemorrhage
Subdural/epidural
hemorrhage
Vasodepressor (vasovagal,
neurocardiogenic)
Situational
Micturition
Post-tussive
Swallow
Defecation
Valsalva (weightlifters)
Carotid sinus sensitivity
Dysrhythmias
Tachydysrhythmias
Supraventricular
tachycardia
Ventricular tachycardia
Ventricular fibrillation
Atrial fibrillation with
fast conduction
Wolff-Parkinson-White
syndrome
Prolonged QT syndrome
Brugada syndrome
Orthostatic
Anemia/GI bleed
Dehydration
Central nervous system /
neurologic
Seizure (excluded by most
syncope studies)
Neuralgias (trigeminal,
glossopharyngeal)
Neurologic (TIA, strokes,
migraines [rare])
Bradydysrhythmias
Atrioventricular block
Atrial fibrillation with
slow conduction
Sick sinus syndrome
Pacemaker malfunction
Metabolic / toxic
Hypoglycemia
Hypoxia
Drug-induced
Carbon monoxide
poisoning
Chemical / toxic gas
exposure
Carotid sinus sensitivity
Infectious agent
Psychogenic
Somatization disorder
Anxiety disorder
Conversion disorder
Panic disorder
Hyperventilation
Breath-holding spells
Tachycardic Dysrhythmias
Tachycardic dysrhythmias cause decreased cardiac output
by not allowing sufficient time for the heart to properly and
completely fill during diastole. Examples include ventricular tachycardia and supraventricular tachycardias such as
atrioventricular reentrant and atrioventricular nodal
reentrant tachycardia as well as atrial fibrillation or atrial
flutter. The atrial tachydysrhythmias may occur in the
setting of Wolff-Parkinson-White syndrome, where there is
an unconcealed bypass tract between the atrial and ventricular myocardial tissue. Ventricular fibrillation can also be
considered a tachydysrhythmia, but in this case loss of
cardiac output may be primarily due to unsynchronized
and ineffective myocardial contraction. Patients with
tachydysrhythmias have a spectrum of presentations from
completely asymptomatic to full cardiac arrest.23
Bradycardic Dysrhythmias
Bradycardic dysrhythmias can also cause syncope. Bradycardia may have an intrinsic cardiologic etiology, such as
dysfunction of the specialized cardiac conduction system at
the level of the sinoatrial or atrioventricular nodes, or within
the His-Purkinje bundle branch fibers. It may also be due to
extrinsic factors, such as excessive cholinergic stimulation or
negative chronotropic poisoning, such as from excessive
beta- or calcium-channel-blocking agents.
Sick sinus syndrome is commonly seen in our aging
population.24,25 This is a dysrhythmia that presents with
periods of normal cardiac rhythm, mixed with sinus
bradycardia, asystolic pauses, and/or sinoatrial block. It can
be a sign of other underlying heart disease. A pacemaker is
generally warranted for treatment of this condition.25
Other bradycardic rhythms that can cause syncope are
the heart blocks. Specifically, second-degree type II heart
block and third degree or complete heart block are common
causes of syncope. If the ventricular escape rhythm is unable
to maintain cerebral perfusion, a syncopal event known as a
Stokes-Adams attack will occur.19,26
Pacemaker malfunction may cause syncope. Possible
etiologies include device malfunction or battery exhaustion,
failure to sense, failure to capture, or disruption of communication such as damage to the leads.27 Careful interrogation
of pacemaker function should be performed by the cardiologist for all patients who present with syncope who have
a pacemaker.
COPYRIGHTED MATERIALDO NOT PHOTOCOPY OR DISTRIBUTE ELECTRONICALLY WITHOUT WRITTEN CONSENT OF EB PRACTICE, LLC
COPYRIGHTED MATERIALDO NOT PHOTOCOPY OR DISTRIBUTE ELECTRONICALLY WITHOUT WRITTEN CONSENT OF EB PRACTICE, LLC
Non-Cardiogenic Syncope
Vasodepressor Syncope
Metabolic Syncope
Neurologic Syncope
Differential Diagnosis
Clearly, the differential diagnosis of syncope is wide. As
always, the emergency clinician should consider the most
lethal diagnoses first. Cardiovascular disease is associated
with the highest long-term mortality, and patients are often
at high risk for recurrent unstable events in the ED as well.
Cardiogenic Syncope
Beyond the usual benefits of a firm diagnosis, there are two
important reasons to correctly identify cardiogenic syncope.
First, syncope from cardiogenic causes has a one-year
mortality rate ranging between 18% and 33%, compared to
0%-12% for non-cardiogenic causes and 6% for unexplained
causes.1,4,5,14,44,45 Second, the treatment of many of the
conditions responsible for cardiogenic syncope has advanced dramatically in the past decade. Many of the
conditions can be successfully treated with medications and
potentially cured with invasive procedures.
One study conducted by Martin et al developed and
validated a clinical prediction rule for risk stratification of
patients with syncope. The authors first derived the
prediction rule by reviewing the charts of 252 patients
presenting to the ED with syncope. The study was validated
using 374 patients. The study found four factors that were
useful for risk stratification: 1) age greater than 45 years; 2)
history of ventricular dysrhythmias; 3) history of congestive
heart failure; and 4) an abnormal ECG. In the validation
cohort, one-year mortality ranged from 1.1% with no risk
factors to 27.3% with three or more risk factors.46 Another
study done by Alboni et al found that the presence of
suspected or certain heart disease on examination was an
independent predictor of a cardiac cause of syncope, with a
sensitivity of 95% and a specificity of 45%. The same study
found that the absence of heart disease on history and
physical examination ruled out a cardiac cause of syncope
in 97% of subjects.47
Cardiac syncope can occur without exertion or while in
a sitting or supine position. In fact, a complaint of syncope
while sitting is highly suggestive of a cardiac origin.
COPYRIGHTED MATERIALDO NOT PHOTOCOPY OR DISTRIBUTE ELECTRONICALLY WITHOUT WRITTEN CONSENT OF EB PRACTICE, LLC
COPYRIGHTED MATERIALDO NOT PHOTOCOPY OR DISTRIBUTE ELECTRONICALLY WITHOUT WRITTEN CONSENT OF EB PRACTICE, LLC
Neurologic Syncope
One of the most difficult mimickers of syncope is seizure, as
it can be difficult to be sure whether a spell was syncope
or a seizure. (See also the October 2000 issue of Emergency
Medicine Practice, Seizures: Accurate Diagnosis And
Vascular Syncope
External or internal hemorrhage due to medical conditions
or trauma may serve as an obvious or occult cause of
1. Limit testing.
Let the history and physical examination dictate the need for
diagnostic tests. Obtaining routine tests like CBCs, electrolyte
studies, CT scans, and echocardiograms has not been proven
beneficial in the literature. While no formal cost-benefit
analyses of limited evaluation of syncope in the ED exist, it
stands to reason that routine tests that do not impact
management will add unnecessary costs.
2. Limit admissions.
Syncope leads over 225,000 hospital admissions per year in
the United States. Elesber et al studied the application of the
ACEP level A and B recommendations for admission in 201
patients presenting with syncope.16 These recommendations
proved to be 100% sensitive for finding cardiac-related causes
of syncope. They also cut down the admission rate by 29%.16
Quinn et al derived a rule for admitting patients that included:
1) age greater than 75; 2) an abnormal ECG; 3) shortness of
breath on presentation; 4) a respiratory rate greater than 24; or
5) a history of congestive heart failure.15 They found this rule to
Metabolic Syncope
Hypoglycemia should be considered in any known diabetic
patient presenting with a syncope-like syndrome. Many
case reports exist in the literature associating syncope and
hypoglycemia.40,41 However, it is difficult to imagine that
hypoglycemia can correct itself without intervention in
order to fit with the standard definition of syncope that
includes spontaneous and full resolution.
Hypoxia can also lead to syncope. Any condition that
leads to a decrease in oxygenation or ventilation can lead to
hypoxia, and ultimately a syncopal episode. This includes a
wide variety of pulmonary and other acute and chronic
disease processes. Keep this diagnosis in mind, particularly
in young children who may play a high-risk game of
inducing syncope by breath-holding, choking each other, or
placing bags over their head until syncope occurs.68
1
1
1
1
1
-2
-2
-2
COPYRIGHTED MATERIALDO NOT PHOTOCOPY OR DISTRIBUTE ELECTRONICALLY WITHOUT WRITTEN CONSENT OF EB PRACTICE, LLC
COPYRIGHTED MATERIALDO NOT PHOTOCOPY OR DISTRIBUTE ELECTRONICALLY WITHOUT WRITTEN CONSENT OF EB PRACTICE, LLC
emia can present with acute loss of consciousness. Methemoglobinemia is caused by a variety of agents, including
nitrates, local anesthetics, and sulfonamides. Pulse oximetry
is unreliable in the setting of both of these poisonings, and
the diagnosis should be made by direct measurement of a
blood sample with a multiple wave-length co-oximeter. In
the setting of smoke inhalation from a residential or
industrial fire and mental status changes, the diagnosis of
cyanide toxicity must also be entertained. In the petroleum,
rubber, and mining industries, exposure to hydrogen sulfide
can cause altered mental status and syncope. Both cyanide
and hydrogen sulfide arrest cellular respiration by interfering with mitochondrial cytochrome function. Cholinergic
and anticholinergic toxidromes may include syncope among
a variety of characteristic symptoms. Toxic exposures
should be in the differential diagnosis of syncope when
several members of the same family or from the same
location present to the ED simultaneously for evaluation.
Infection-Related Syncope
History
The cause of syncope is revealed by a careful history and
physical examination in approximately 40%-50% of
patients.1,2,4-6,47,71 A detailed account of the syncopal episode
from any bystanders or family members can be very helpful
in the diagnosis. Table 3 is a list of important historical
features that should be asked of syncopal patients.14
Is It Really Syncope?
Psychiatric Syncope
Psychiatric conditions can mimic syncope. They can range
from fully conscious actions for secondary gain purposes to
dissociative states where the patient has no conscious
control over the activity. While psychiatric conditions that
mimic syncope exist, they must remain a diagnosis of
exclusion. A study by Kapoor et al of syncope patients
found that up to 20% of the population studied met
diagnostic criteria for at least one major psychiatric disorder
or substance abuse problem. Up to one-half of these patients
with a psychiatric disorder did not have their disorder
identified by the attending physician. This study found that
patients who have suffered a syncopal event and carry a
psychiatric diagnosis were more likely to report frequent
episodes of syncope (four or more within one year), to be
younger than control groups who did not have a psychiatric
diagnosis, and to have multiple somatic complaints
associated with the event.69
Prehospital Care
Prehospital care of patients with syncope and altered mental
status should include a fundamental diagnostic and
therapeutic protocol. Assessment for and/or treatment of
hypoglycemia and hypoxia should be completed. Naloxone
should be administered for depressed consciousness and
possible opiate intoxication. Occult head trauma must be
considered, and the neck should be immobilized if there is a
suspicion of trauma or the patient suffered an injury to the
head or neck from syncope. An IV catheter should be placed
if the patient is hypotensive or tachycardic. Recall that in the
setting of trauma, hypotension in the field is an independent
predictor of morbidity and mortality, even if the patient is
normotensive upon ED arrival.70
The Event
Finding out exactly what happened is the goal of the initial
evaluation. Taking the time to obtain a step-by-step history
of the acute event may be the most important factor in
ultimately making an accurate diagnosis. Interview the
patient and, ideally, a witness to the event. Although the
patient can be very helpful in discussing what may have
happened just before the event, any past history of similar
episodes, and current status, he or she may not recall the
actual event. A witness (family member, friend, neighbor,
EMS provider, or other bystander) can relate such information as duration of unconsciousness, evidence of movements suggesting a seizure, events just prior to the spell,
duration of confusion following the spell, and/or other
important details. A witness may also be able to predict
other potential associated injuries.
Certain clusters of historical information can help
indicate the right direction when trying to determine the
cause of the syncopal episode. For instance, a history of a
stressful event or other obvious precipitating circumstances
may suggest a vasodepressor cause of syncope. A syncopal
episode that occurs only after standing may point to
orthostasis or hypovolemia. A complaint of cough and
dyspnea in association with syncope suggests possible
pulmonary embolism or other obstructive cardiopulmonary
disease. Any associated focal neurologic deficits suggest an
underlying neurologic event. Rapid onset and offset with no
warning before, or confusion after, the event suggests a
transient dysrhythmia or other cardiac cause.4,46,49,71 One
study found that most patients with otherwise typical
vasovagal syncope had warning symptoms for minutes
prior to the syncopal event. In fact, the study stated that in
the absence of any warning signs or symptoms, the practitioner should be leery about making the diagnosis of
vasovagal syncope.4
Continued on page 11
COPYRIGHTED MATERIALDO NOT PHOTOCOPY OR DISTRIBUTE ELECTRONICALLY WITHOUT WRITTEN CONSENT OF EB PRACTICE, LLC
NO
YES
Findings of
life threat?
NO
Elderly
Congestive heart
failure
Abnormal ECG
Acute coronary
syndrome /
coronary artery
disease
Young
Normal ECG
Prodrome
suggesting
vasodepressor or
orthostatic
etiology
High risk
Intermediate risk
Low risk
YES
Consider:
Pulmonary
embolism
Subarachnoid
hemorrhage
Aortic dissection/
aneurysm
Myocardial
infarction
Gastrointestinal
bleed
Ventricular
dysrhythmia
Heart block
Carbon monoxide
poisoning
COPYRIGHTED MATERIALDO NOT PHOTOCOPY OR DISTRIBUTE ELECTRONICALLY WITHOUT WRITTEN CONSENT OF EB PRACTICE, LLC
Consider
admission
(Class II)
Possible ED
observation
unit stay
(Class III)
Outpatient
workup if
available
promptly
and patient
is reliable
(Class III)
Discharge to home
with primary care
follow-up (Class II)
The evidence for recommendations is graded using the following scale. For complete definitions, see back page. Class I: Definitely
recommended. Definitive, excellent evidence provides support. Class II: Acceptable and useful. Good evidence provides support. Class III:
May be acceptable, possibly useful. Fair-to-good evidence provides support. Indeterminate: Continuing area of research.
This clinical pathway is intended to supplement, rather than substitute for, professional judgment and may be changed depending
upon a patients individual needs. Failure to comply with this pathway does not represent a breach of the standard of care.
Copyright 2004 EB Practice, LLC. 1-800-249-5770. No part of this publication may be reproduced in any format
without written consent of EB Practice, LLC.
10
Physical Findings
Due to time constraints, ambient noise, and numerous
distractions, it can be a challenge to perform a quality
cardiac and neurologic examination in the ED. Several key
features are important. For example, the presence of a new
murmur may suggest a cardiac etiology of syncope.
11
COPYRIGHTED MATERIALDO NOT PHOTOCOPY OR DISTRIBUTE ELECTRONICALLY WITHOUT WRITTEN CONSENT OF EB PRACTICE, LLC
COPYRIGHTED MATERIALDO NOT PHOTOCOPY OR DISTRIBUTE ELECTRONICALLY WITHOUT WRITTEN CONSENT OF EB PRACTICE, LLC
Diagnostic Testing
Electrocardiography
An ECG should be performed on most patients with
syncope. Although the chance of finding the cause of
syncope is 2%-12% with the ECG alone,4,12 the cardiac causes
can be extremely dangerous and potentially lethal. An ECG
is easy to obtain, is relatively inexpensive, and can lead to
immediate treatment of life-threatening problems. The ECG
yields information beyond the rate and rhythm. Examples
include ischemic changes, a short PR interval and delta
wave suggestive of Wolff-Parkinson-White syndrome, a
prolonged QT interval, evidence of right heart strain, and/
or evidence of Brugada syndrome.
A completely normal ECG can also be used to risk
stratify patients. Georgeson et al searched for evidence of
acute cardiac ischemia in patients who presented with
syncope without chest pain and found that 18 of 251
patients were ultimately diagnosed with acute cardiac
ischemia, all of whom had ischemic abnormalities on their
presenting ECGs.81 Thus, a patient with no chest pain or
cardiac risk factors and a normal ECG is unlikely to have an
ischemic cause for syncope.
A normal ECG also lowers the likelihood of a primary
dysrhythmic cause for syncope. The ECG can be supplemented with continuous ECG monitoring in the ED, and
outpatient ambulatory cardiac event recording. Continuous
ECG monitoring in the ED with periodic physician inspection of the 12-lead tracing increases the diagnostic yield for
ongoing ischemia.82 Cardiac event recorders with continuous automatic dysrhythmia detection increase the sensitivity for relevant dysrhythmia detection when worn for 2-4
days after a syncopal event.83 The latest innovation in this
field is the subcutaneously implantable loop recorder.
Recording can be activated automatically or manually, and
the device can be implanted for one year or more.84,85
Chest X-Ray
The chest x-ray is a commonly ordered test in patients
presenting with syncope. Its value is less well-established
12
Electrolytes/Glucose
Electrolytes are defined as sodium, potassium, chloride,
bicarbonate, blood urea nitrogen, and creatinine. In one
prospective study, only one non-suspected abnormality was
detected in 134 electrolyte and/or glucose panels. This was
a case of a serum sodium level of 101 mEq/L in a patient
with diuretic-induced orthostasis.4 In a retrospective review,
five of 130 tests drawn proved helpful, although only one
was an unexpected metabolic abnormality.1 Another
retrospective study found that by dividing the electrolyte
panel into individual components, two abnormalities that
proved helpful were identified in 33 patients.18 In the same
study, the blood urea nitrogen and creatinine values
contributed to the decision to admit one of 33 cases by
confirming the clinical impression of dehydration.18 In
general, drawing routine electrolyte panels on patients
with syncope is not supported by the literature; it should
be guided by the medical history and medications of
the patient.
Electroencephalography
As with obtaining a head CT, an electroencephalogram
(EEG) is only indicated if there is a suggestive finding in the
history and physical examination. Several studies have been
performed regarding the use of EEG as a diagnostic tool.12,86
Little evidence exists of its benefit in a syncope patient with
no history of seizure activity. This test is unlikely to uncover
the cause of syncope if it was not already suggested by the
history and physical examination. Therefore, the routine use
of an EEG is not recommended.
Echocardiography
The literature regarding the use of echocardiography as a
screening tool for syncope is mixed. Some case reports have
shown a benefit to the use of echocardiography, but larger
studies have found this not to be the case. Unsuspected
causes of syncope found on echocardiography are reported
in 5%-10% of patients.13,71,85,87,88 The European Task Force
Guidelines on the management of syncope gives echocardiography a Class I recommendation for use in patients
with syncope when cardiac disease is suspected.14 The
problem is that echocardiography is not readily available in
most EDs. Although the diagnostic benefit may be similar to
that of the ECG, the fact that a formal study is up to seven
times the cost and that it is not readily available makes it
difficult to recommend this test for routine use in the ED.13
Echocardiography should be performed when cardiac
disease is suspected, but in patients with no underlying
cardiac history, no cardiac symptoms, and a normal physical
examination, echocardiography is likely to add little to the
diagnostic evaluation.
Laboratory Testing
13
COPYRIGHTED MATERIALDO NOT PHOTOCOPY OR DISTRIBUTE ELECTRONICALLY WITHOUT WRITTEN CONSENT OF EB PRACTICE, LLC
COPYRIGHTED MATERIALDO NOT PHOTOCOPY OR DISTRIBUTE ELECTRONICALLY WITHOUT WRITTEN CONSENT OF EB PRACTICE, LLC
Other Studies
No studies currently support the routine ED use of liver
enzymes, arterial blood gasses, toxicology screens, coagulation studies, or urine dipsticks for screening purposes.
Abnormalities have been found in all of these test groups;
however, random screening is not justified unless clinically
indicated by the history and physical examination.
Management
The wide range of causes of syncope results in an even
wider range of possible treatment strategies. The goal in the
ED is to identify life threats and treat them accordingly.
When no immediate life threat is identified, the goal shifts to
risk stratifying the patient for likelihood of an adverse
outcome. However, in about one-third to one-half of cases, it
may also be possible to identify the cause of syncope. Table
4 lists the common causes of syncope and the potential
treatments for each cause. At this time, there are no largescale, randomized, controlled trials studying the advantages
and disadvantages of inpatient vs. outpatient management
of patients with syncope. (See the disposition section later in
this article.)
Special Circumstances
Pediatric Syncope
Syncope in children is generally a benign event. As stated
earlier, up to 20% of patients experience syncope before the
end of adolescence.2,3,92 There are a few serious, but rare,
causes of syncope in children.
Little research is done in this population. The only
population-based study of syncope in children to date was
done by Driscoll et al.93 The study examined 151 patients
between the ages of 1 and 22 years presenting between 1987
and 1991 with symptoms consistent with syncope. The
authors estimated that the incidence of syncopal episodes in
children coming to medical attention per 100,000 population
was 125.8. For both male and female patients, the rate of
syncopal episodes peaked in the 15- to 19-year-old age
groups, but the peak for female patients was much greater
than that in males. Only one patient was ultimately found to
have a long QT syndrome. The majority of children were
thought by the evaluating physician to have had vasodepressor syncope. Recurrence of syncopal episodes occurred
in 9% of the 151 patients. No deaths related to syncope were
reported in this group of children at follow-up.93
Just as in their adult counterparts, a detailed history
and physical examination may be sufficient to define the
cause of syncope in many cases.3,93-95 In a recent review
by McLeod, several anecdotal but useful warning bells
in the history are defined. They include: 1) syncope in
response to loud noise, fright, or extreme emotional stress;
III. Dysrhythmias
Bradycardia
Discontinue / decrease medications if can be done safely
A permanent pacemaker is generally indicated for
symptomatic bradycardia and high-grade AV block
Tachycardia
Ventricular tachycardiaACLS guidelines for immediate
treatment, electrophysiologic testing may be warranted;
possible automatic implantable cardioverter/defibrillator
placement, antidysrhythmic therapy, or radio frequency
catheter ablation as needed
Supraventricular tachycardiaACLS guidelines for
immediate treatment, ED studies with radiofrequency
catheter ablation may be warranted
14
Elderly Patients
Disposition
15
COPYRIGHTED MATERIALDO NOT PHOTOCOPY OR DISTRIBUTE ELECTRONICALLY WITHOUT WRITTEN CONSENT OF EB PRACTICE, LLC
COPYRIGHTED MATERIALDO NOT PHOTOCOPY OR DISTRIBUTE ELECTRONICALLY WITHOUT WRITTEN CONSENT OF EB PRACTICE, LLC
strategies on page 6.
Also, be sure to consider the social situation of the
patient, the ability to get a follow-up appointment in a
particular institution or community, and the patients
wishes. All of these factors may alter management.
Discharge Instructions
Driving Recommendations
Should people who suffer from syncope be limited from
driving? Driving an automobile is not a guaranteed right
it is a privilege that may be restricted when it poses a threat
to other people. The occurrence of a syncopal episode
during driving could have serious consequences to the
patient, his or her passengers, and others on the roads. Laws
exist in many municipalities regarding what is required
when a patient has a syncopal episode.103,104 Physicians
should be aware of the laws in the state in which they
practice. In 1996, the American Heart Association and the
North American Society of Pacing and Electrophysiology
issued statements regarding driving after syncope.107,108
A study by Akiyama et al found that 2% of syncopal
patients reported losing consciousness while driving.105
Only a small number of patients reported having an
accident while driving. They concluded that although it was
common for their patients to have symptoms of possible
dysrhythmia while driving, accidents were found to be
uncommon; they actually occurred at a lower frequency
than the annual accident rate of the general population.105
Another study by Maas et al examined patient compliance
with no driving advice given by their doctor.106 They
found that three of 104 patients instructed not to drive
reported a syncopal episode while driving within the next
year. This resulted in one car crash with minor injury. Nine
patients had stopped driving prior to the initial evaluation
by the investigative team. On follow-up, all 95 patients who
had been driving prior to being told to stop had continued
to drive irrespective of any recommendations.106
Everyone Else
Finally, another group represents the gray area. The ACEP
guidelines define this group of patients as having: 1) age
greater than 60; 2) a history of congenital heart disease; 3) a
history of coronary artery disease in the absence of chest
pain or ischemia during the examination; 4) a family history
of unexpected sudden death; or 5) exertional syncope in
younger patients without an obvious benign etiology.11 This
includes a large number of patients who present with
syncope, and some clinical judgment is required. These
patients may be good candidates for an observation unit.
This is discussed in detail in the section on cost-effective
Summary
For treatment
Cardiac dysrhythmias
causing syncope
Syncope due to acute
coronary syndrome
Syncope due to structural
cardiac disease
Stroke or focal neurologic
disorders
Patients with repeat
vasodepressor syncope for
which pacemaker
implantation is planned
References
Evidence-based medicine requires a critical appraisal of the
literature based upon study methodology and number of
subjects. Not all references are equally robust. The findings
of a large, prospective, randomized, and blinded trial
16
1.*
17
COPYRIGHTED MATERIALDO NOT PHOTOCOPY OR DISTRIBUTE ELECTRONICALLY WITHOUT WRITTEN CONSENT OF EB PRACTICE, LLC
COPYRIGHTED MATERIALDO NOT PHOTOCOPY OR DISTRIBUTE ELECTRONICALLY WITHOUT WRITTEN CONSENT OF EB PRACTICE, LLC
associated with probable adverse drug reactions. Arch Intern Med 1990
Nov;150(11):2309-2312. (Retrospective; 70 patients)
75. Gaeta TJ, Fiorini M, Ender K, et al. Potential drug-drug interactions in
elderly patients presenting with syncope. J Emerg Med 2002
Feb;22(2):159-162. (Retrospective; 263 patients)
76. Atkins D, Hanusa B, Sefcik T, et al. Syncope and orthostatic hypotension. Am J Med 1991 Aug;91(2):179-185. (Prospective; 223 patients)
77. Sarasin FP, Louis-Simonet M, Carballo D, et al. Prevalence of
orthostatic hypotension among patients presenting with syncope in
the ED. Am J Emerg Med 2002 Oct;20(6):497-501. (Prospective; 650
patients)
78. Goldschlager N, Epstein AE, Grubb BP, et al; Practice Guidelines
Subcommittee, North American Society of Pacing and Electrophysiology. Etiologic considerations in the patient with syncope and an
apparently normal heart. Arch Intern Med 2003 Jan 27;163(2):151-162.
(Review)
79. Meyer MD, Handler J. Evaluation of the patient with syncope: an
evidence based approach. Emerg Med Clin North Am 1999
Feb;17(1):189-201, ix. (Review)
80. Chen LY, Gersh BJ, Hodge DO, et al. Prevalence and clinical outcomes
of patients with multiple potential causes of syncope. Mayo Clin Proc
2003 Apr;78(4):414-420. (Retrospective cohort; 987 patients)
81. Georgeson S, Linzer M, Griffith JL, et al. Acute cardiac ischemia in
patients with syncope: importance of the initial electrocardiogram. J
Gen Intern Med 1992 Jul-Aug;7(4):379-386. (Prospective, multicenter;
251 patients)
82. Fesmire FM, Percy RF, Bardoner JB, et al. Usefulness of automated
serial 12-lead ECG monitoring during the initial emergency
department evaluation of patients with chest pain. Ann Emerg Med
1998 Jan;31(1):3-11. (Prospective, observational; 1000 patients)
83. Balmelli N, Naegeli B, Bertel O. Diagnostic yield of automatic and
patient-triggered ambulatory cardiac event recording in the evaluation
of patients with palpitations, dizziness, or syncope. Clin Cardiol 2003
Apr;26(4):173-176. (Prospective cohort; 101 patients)
84. Seidl K, Rameken M, Breunung S, et al; Reveal-Investigators.
Diagnostic assessment of recurrent unexplained syncope with a new
subcutaneously implantable loop recorder. Europace 2000 Jul;2(3):256262. (Prospective cohort; 133 patients)
85. Arthur W, Kaye GC. Current investigations used to assess syncope.
Postgrad Med J 2001 Jan;77(903):20-23. (Review)
86. Davis TL, Freemon FR. Electroencephalography should not be routine
in the evaluation of syncope in adults. Arch Intern Med 1990
Oct;150(10):2027-2029. (Retrospective; 73 patients)
87. Recchia D, Barzilai B. Echocardiography in the evaluation of patients
with syncope. J Gen Intern Med 1995 Dec;10(12):649-655. (Retrospective; 128 patients)
88. Sarasin FP, Junod AF, Carballo D, et al. Role of echocardiography in the
evaluation of syncope: a prospective study. Heart 2002 Oct;88(4):363367. (Prospective cohort; 650 patients)
89. Morag R, Brenner B. Syncope. http://www.emedicine.com/. Accessed
September 27, 2002. (Review)
90. Widerhorn J, Widerhorn AL, Rahimtoola SH, et al. WPW syndrome
during pregnancy: increased incidence of supraventricular
arrhythmias. Am Heart J 1992 Mar;123(3):796-798. (Case series; 3
patients)
91. Shotan A, Ostrzega E, Mehra A, et al. Incidence of arrhythmias in
normal pregnancy and relation to palpitations, dizziness, and syncope.
Am J Cardiol 1997 Apr 15;79(8):1061-1064. (Comparative; 162 patients)
92. Lewis DA, Dhala A. Syncope in the pediatric patient. The
cardiologists perspective. Pediatr Clin North Am 1999 Apr;46(2):205219. (Review)
93.* Driscoll DJ, Jacobsen SJ, Porter CJ, et al. Syncope in children and
adolescents. J Am Coll Cardiol 1997 Apr;29(5):1039-1045. (Retrospective;
151 patients)
94. Prodinger RJ, Reisdorff EJ. Syncope in children. Emerg Med Clin North
Am 1998 Aug;16(3):617-626, ix. (Review)
95. Johnsrude CL. Current approach to pediatric syncope. Pediatr Cardiol
2000 Nov-Dec;21(6):522-531. (Review)
96. Driscoll DJ, Edwards WD. Sudden unexpected death in children and
adolescents. J Am Coll Cardiol 1985 Jun;5(6 Suppl):118B-121B.
(Retrospective; 515 patients)
97. Olsky M, Murray J. Dizziness and fainting in the elderly. Emerg Med
Clin North Am 1990 May;8(2):295-307. (Review)
98. Baraff LJ, Della Penna R, Williams N, et al. Practice guideline for the
ED management of falls in community-dwelling elderly persons.
Kaiser Permanente Medical Group. Ann Emerg Med 1997 Oct;30(4):480492. (Practice guideline, review)
99. Sorock GS. Falls among the elderly: epidemiology and prevention. Am
18
2.
3.
4.
5.
7.
8.
9.
A brief, transient loss of consciousness plus generalized weakness and loss of muscular tone characterize:
a. seizures.
b. syncope.
c. vertigo.
d. drop attacks.
6.
19
COPYRIGHTED MATERIALDO NOT PHOTOCOPY OR DISTRIBUTE ELECTRONICALLY WITHOUT WRITTEN CONSENT OF EB PRACTICE, LLC
COPYRIGHTED MATERIALDO NOT PHOTOCOPY OR DISTRIBUTE ELECTRONICALLY WITHOUT WRITTEN CONSENT OF EB PRACTICE, LLC
15. An ECG:
a. can identify extremely dangerous and potentially
lethal causes of syncope.
b. is easy, inexpensive, and can facilitate rapid
treatment of life-threatening problems.
c. can be used to risk stratify patients with syncope.
d. all of the above.
This CME enduring material is sponsored by Mount Sinai School of Medicine and
has been planned and implemented in accordance with the Essentials and
Standards of the Accreditation Council for Continuing Medical Education. Credit
may be obtained by reading each issue and completing the printed post-tests
administered in December and June or online single-issue post-tests
administered at www.empractice.net.
Target Audience: This enduring material is designed for emergency medicine
physicians.
Needs Assessment: The need for this educational activity was determined by a
survey of medical staff, including the editorial board of this publication; review
of morbidity and mortality data from the CDC, AHA, NCHS, and ACEP; and
evaluation of prior activities for emergency physicians.
Date of Original Release: This issue of Emergency Medicine Practice was published
January 1, 2004. This activity is eligible for CME credit through January 1,
2007. The latest review of this material was December 5, 2003.
Discussion of Investigational Information: As part of the newsletter, faculty may
be presenting investigational information about pharmaceutical products that
is outside Food and Drug Administration approved labeling. Information
presented as part of this activity is intended solely as continuing medical
education and is not intended to promote off-label use of any pharmaceutical
product. Disclosure of Off-Label Usage: This issue of Emergency Medicine Practice
discusses no off-label use of any pharmaceutical product.
Faculty Disclosure: In compliance with all ACCME Essentials, Standards, and
Guidelines, all faculty for this CME activity were asked to complete a full
disclosure statement. The information received is as follows: Dr. Marill, Dr. Kosiak,
Dr. Decker, Dr. Pigott, and Dr. Shah report no significant financial interest or
other relationship with the manufacturer(s) of any commercial product(s)
discussed in this educational presentation.
Indeterminate
Continuing area of research
No recommendations until
further research
Level of Evidence:
Evidence not available
Higher studies in progress
Results inconsistent,
contradictory
Results not compelling
Emergency Medicine Practice is not affiliated with any pharmaceutical firm or medical device manufacturer.
President and CEO: Robert Williford. Publisher: Heidi Frost. Research Editors: Ben Abella, MD, University of Chicago; Richard Kwun, MD, Mount Sinai School of Medicine.
Direct all editorial or subscription-related questions to EB Practice, LLC: 1-800-249-5770 Fax: 1-770-500-1316 Non-U.S. subscribers, call: 1-678-366-7933
EB Practice, LLC 305 Windlake Court Alpharetta, GA 30022
E-mail: emp@empractice.net Web Site: http://www.empractice.net
Emergency Medicine Practice (ISSN 1524-1971) is published monthly (12 times per year) by EB Practice, LLC, 305 Windlake Court, Alpharetta, GA 30022. Opinions expressed are not necessarily
those of this publication. Mention of products or services does not constitute endorsement. This publication is intended as a general guide and is intended to supplement, rather than
substitute, professional judgment. It covers a highly technical and complex subject and should not be used for making specific medical decisions. The materials contained herein are not
intended to establish policy, procedure, or standard of care. Emergency Medicine Practice is a trademark of EB Practice, LLC. Copyright 2004 EB Practice, LLC. All rights reserved. No part of this
publication may be reproduced in any format without written consent of EB Practice, LLC. Subscription price: $299, U.S. funds. (Call for international shipping prices.)
20